Kura Oncology, Inc.(KURA)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | Powl Brian T. Chief Commercial Officer | Sale | -10,000 | -5.45%173,614 | $11.00 | $110,000 | View SEC filing | |
| 2026-05-20 | FORD KATHLEEN Chief Operating Officer | Sale | -2,257 | -1.45%153,560 | $9.08 | $20,483 | View SEC filing | |
| 2026-05-20 | Powl Brian T. Chief Commercial Officer | Sale | -339 | -0.18%183,614 | $9.21 | $3,122 | View SEC filing | |
| 2026-05-20 | Bair Teresa Brophy Chief Legal Officer | Sale | -2,256 | -0.98%226,931 | $9.38 | $21,160 | View SEC filing | |
| 2026-01-27 | Burrows Francis Chief Scientific Officer | Sale | -1,311 | -3.89%32,424 | $8.46 | $11,092 | View SEC filing | |
| 2026-01-27 | Powl Brian T. Chief Commercial Officer | Sale | -6,414 | -3.38%183,275 | $8.46 | $54,266 | View SEC filing | |
| 2026-01-27 | FORD KATHLEEN Chief Operating Officer | Sale | -1,813 | -1.17%153,560 | $8.46 | $15,339 | View SEC filing | |
| 2026-01-27 | Leoni Mollie Chief Medical Officer | Sale | -8,180 | -2.97%267,274 | $8.46 | $69,209 | View SEC filing | |
| 2026-01-27 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | -7,142 | -4.69%145,167 | $8.46 | $60,426 | View SEC filing | |
| 2026-01-27 | Bair Teresa Brophy Chief Legal Officer | Sale | -11,208 | -4.71%226,931 | $8.46 | $94,828 | View SEC filing | |
| 2025-12-19 | Burrows Francis Chief Scientific Officer | Sale | -23,726 | -41.29%33,735 | $9.78 | $231,931 | View SEC filing | |
| 2025-12-10 | Hasnain Faheem Director | Sale | -10,000 | -29.43%23,983 | $10.98 | $109,764 | View SEC filing | |
| 2025-11-14 | Bair Teresa Brophy Chief Legal Officer | Sale | -8,804 | -4.47%188,139 | $11.18 | $98,401 | View SEC filing | |
| 2025-11-14 | Powl Brian T. Chief Commercial Officer | Sale | -8,887 | -5.98%139,689 | $11.18 | $99,329 | View SEC filing | |
| 2025-11-14 | Leoni Mollie Chief Medical Officer | Sale | -15,485 | -6.43%225,454 | $11.18 | $173,074 | View SEC filing | |
| 2025-11-14 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | -4,539 | -3.37%130,257 | $11.18 | $50,732 | View SEC filing | |
| 2025-11-14 | FORD KATHLEEN Chief Operating Officer | Sale | -6,902 | -6.15%105,373 | $11.18 | $77,143 | View SEC filing | |
| 2025-09-29 | Powl Brian T. Chief Commercial Officer | Sale | -8,891 | -8.19%99,676 | $8.94 | $79,505 | View SEC filing | |
| 2025-09-29 | Bair Teresa Brophy Chief Legal Officer | Sale | -8,805 | -5.61%148,043 | $8.94 | $78,736 | View SEC filing | |
| 2025-09-29 | FORD KATHLEEN Chief Operating Officer | Sale | -6,892 | -9.81%63,375 | $8.94 | $61,630 | View SEC filing | |
| 2025-09-29 | Leoni Mollie Chief Medical Officer | Sale | -12,314 | -7.21%158,439 | $8.94 | $110,114 | View SEC filing | |
| 2025-09-29 | WILSON TROY EDWARD President and CEO | Sale | -36,615 | -12.92%246,853 | $8.94 | $327,419 | View SEC filing | |
| 2025-09-29 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | -4,541 | -3.97%109,829 | $8.94 | $40,607 | View SEC filing | |
| 2025-09-09 | WILSON TROY EDWARD President & CEO | Purchase | +50,000 | +98.10%100,968 | $8.20 | $410,145 | View SEC filing | |
| 2025-08-14 | WILSON TROY EDWARD President and CEO | Purchase | +50,000 | +5165.29%50,968 | $6.06 | $303,201 | View SEC filing |
1-25 of 65